Head and Neck Squamous Cell Carcinoma (HNSCC) Terminated Phase 2 Trials for DB08916 (Afatinib)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01824823Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of RecurrenceTreatment